Verseon is an AI-powered drug company – in theory, anyway. The Bay Area startup does use machine learning to help predict which combination of molecules will yield novel compound to test in the lab. With over a dozen drug candidates at different stages of development, Verseon’s approach seems to be working. So when the company’s CEO had some choice words about AI, it was a little bit surprising.
The post Why AI Alone Won’t Solve Drug Discovery appeared first on HPCwire.
Prior to the Covid pandemic, robotics deployments in retail environments were growing...
Quantinuum – the newly-named company resulting from the merger of Honeywell’s quantum...
There are close to five to six quantum computing technologies being developed,...
Highly Niched Headhunters Specialized in Physical AI/Robotics, High-Performance Computing, Unmanned/Autonomous Systems, Defense Technology and Energy.
We recruit across complex engineering markets where understanding the technology is critical to finding the right talent.
Overview of how PACE partners with teams: Our process, what clients get, and why PACE is different.
PACE’s story, values, and culture define how we operate and who we are.
Stay up to date on industry trends.
All the information needed for anyone interested in contacting us.
